305 related articles for article (PubMed ID: 12397143)
1. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.
Ghaemi M; Hilker R; Rudolf J; Sobesky J; Heiss WD
J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):517-23. PubMed ID: 12397143
[TBL] [Abstract][Full Text] [Related]
2. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
3. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Antonini A; Leenders KL; Vontobel P; Maguire RP; Missimer J; Psylla M; Günther I
Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
Eur J Neurol; 2008 Oct; 15(10):1043-9. PubMed ID: 18717730
[TBL] [Abstract][Full Text] [Related]
5. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
[TBL] [Abstract][Full Text] [Related]
6. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
Otsuka M; Kuwabara Y; Ichiya Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
Ann Nucl Med; 1997 Aug; 11(3):251-7. PubMed ID: 9310175
[TBL] [Abstract][Full Text] [Related]
7. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease.
Kwon KY; Choi CG; Kim JS; Lee MC; Chung SJ
Mov Disord; 2007 Dec; 22(16):2352-8. PubMed ID: 17894342
[TBL] [Abstract][Full Text] [Related]
8. The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy.
Baudrexel S; Seifried C; Penndorf B; Klein JC; Middendorp M; Steinmetz H; Grünwald F; Hilker R
Mov Disord; 2014 Mar; 29(3):380-7. PubMed ID: 24243813
[TBL] [Abstract][Full Text] [Related]
9. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
10. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.
Lee H; Sung YH; Hwang KH
Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891
[TBL] [Abstract][Full Text] [Related]
11. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?
Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL
Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850
[TBL] [Abstract][Full Text] [Related]
12. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
Burn DJ; Sawle GV; Brooks DJ
J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):278-84. PubMed ID: 8158173
[TBL] [Abstract][Full Text] [Related]
14. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
15. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
[TBL] [Abstract][Full Text] [Related]
16. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.
Rakshi JS; Uema T; Ito K; Bailey DL; Morrish PK; Ashburner J; Dagher A; Jenkins IH; Friston KJ; Brooks DJ
Brain; 1999 Sep; 122 ( Pt 9)():1637-50. PubMed ID: 10468504
[TBL] [Abstract][Full Text] [Related]
17. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.
Barbagallo G; Sierra-Peña M; Nemmi F; Traon AP; Meissner WG; Rascol O; Péran P
Mov Disord; 2016 Mar; 31(3):325-34. PubMed ID: 26676922
[TBL] [Abstract][Full Text] [Related]
18. [Striatonigral degeneration].
Mochizuki A; Shimizu T
Nihon Rinsho; 1997 Jan; 55(1):123-6. PubMed ID: 9014434
[TBL] [Abstract][Full Text] [Related]
19. [The clinical application value of brain
Gu Q; Chen SF; Chen KL; Huang YY; Ge JJ; Zuo CT; Cui M; Dong Q; Yu JT
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(41):3294-3300. PubMed ID: 37926574
[No Abstract] [Full Text] [Related]
20. Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease.
Kaasinen V; Maguire RP; Hundemer HP; Leenders KL
J Neurol; 2006 Mar; 253(3):340-8. PubMed ID: 16222426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
